Lv11
50 积分 2024-03-15 加入
In vivo CAR-T therapy: Delivery systems and beyond for addressing expression, persistence, and safety challenges
6天前
已完结
In vivo chimeric antigen receptor T cell therapy: From mechanistic innovation to clinical translation
9天前
已完结
Advancing In Vivo Chimeric Antigen Receptor T-Cell Engineering to Accelerate Clinical Translation
1个月前
已完结
In vivo CAR T-cell therapy: determinants of response and durability
1个月前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
2个月前
已完结
Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: an immunofluorescence and immunoelectron microscopy study
2个月前
已完结
Rewiring immunity with in vivo CAR T cell engineering
2个月前
已完结
Generation of Simian-Tropic HIV-1 by Restriction Factor Evasion
2个月前
已完结
Engineering T cells in vivo to express a synthetic cytokine receptor enables preferential expansion and enrichment of anti-CD22 CAR T cells
3个月前
已完结
The landscape of genetic medicines for in vivo T cell reprogramming
3个月前
已完结
皖公网安备34019202002308
